Economics of Innovation
Optimal innovation balances willingness and ability to pay with the benefits of future R&D. Our wide-ranging programme aims to promote innovation in health care, increase our understanding of its value, and encourage R&D. New models of innovation should streamline development, reduce costs, and speed patient benefit.
Pharmaceuticals in Developing Countries
1 July 1983
The Office of Health Economics has recently widened its scope to take a special interest in the health care problems of the Poor World, with particular…
Second Pharmacological Revolution
1 July 1983
The published proceedings of the symposium held at the Royal College of Physicians, London in September 1982 by the Office of Health Economics to mark the…
Future for Pharmaceuticals: the Potential; the Pattern and the Problems
1 June 1983
Britain has very little to be proud of on the industrial front in the 1980s. Many of its traditional industries — the so-called ‘smokestack industries’ —…
Issues in Development: a Guide
5 January 1983
Unlike the great majority of OHE publications, this paper was not researched and written ‘in-house’. It is a minimally edited translation of a study prepared in…
Needs of the Pharmaceutical Manufacturers from Their Medical Departments in the 1980s
1 February 1983
This paper was originally written for the benefit of a single pharmaceutical company. However the company agreed when it was commissioned that it should be made…
Consumer Movement, Health, and the Pharmaceutical Industry
1 January 1983
In his Inquiry into the Nature and Causes of the Wealth of Nations, which was first published in 1776, Adam Smith placed special emphasis on the…
Adverse Reactions and the Community
1 November 1982
Conference of Scottish Pharmacists, Aviemore, 21 November 1982. The aim is to do two things. First, to put the experience with benoxaprofen into a broader and…
Costs and Benefits of Regulating New Product Development in the UK Pharmaceutical Industry
3 January 1982
This is the second in an occasional series of Pharmaceutical Industry Papers to be published by OHE. The first concerned prices; this second paper is concerned,…
Price Comparisons of Identical Products in Japan, the United States and Europe
1 August 1981
The promotion of an environment in which the multinational research-based pharmaceutical industry can flourish has been and will continue to be reliant upon a well-informed and…